Protein Chip Update: Ciphergen Reports Solid Q1, Outlines Plans for New Chip | GenomeWeb

Riding high on a flurry of positive press coverage, protein profiling biochip company Ciphergen reported that its revenues had risen to $6.8 million for the first quarter, from $2.7 million in the first quarter of 2001. The company also laid out plans to further develop its protein arrays and patent protein biomarkers.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.